MAPT and Alzheimer disease: A comprehensive study involving the ADNI and BioFINDER cohorts has verified elevated plasma tau concentrations in patients with Alzheimer’s disease dementia and marked correlations between levels of plasma tau and subsequent cognitive deterioration [103].